Abeona Therapeutics Inc (ABEO):企業の財務・戦略的SWOT分析

◆英語タイトル:Abeona Therapeutics Inc (ABEO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH55346FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Abeona Therapeutics Inc (ABEO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company that develops and delivers gene therapy and plasma-based products for severe life-threatening rare diseases. The company’s lead programs include ABO-101 and ABO-102 adeno-associated virus. Abeona also develops EB-101 for recessive dystrophic epidermolysis bullosa (RDEB), EB-201 for epidermolysis bullosa (EB), ABO-202 (AAV-CLN1) gene therapy for treatment of infantile Batten disease (INCL), ABO-201 (AAV-CLN3) gene therapy for juvenile Batten disease (JNCL) and more. The company has partnerships for the commercialization of its products in the US, European Union, Switzerland, Norway, Iceland, Lichtenstein, Australia, New Zealand, China and South Korea. Abeona is headquartered in New York City, the US.

Abeona Therapeutics Inc Key Recent Developments

Mar 25,2021: Abeona Therapeutics Announces Appointment of Two New Independent Members to its Board of Directors
Mar 24,2021: Abeona Therapeutics Announces 2020 Financial Results and Recent Operational Progress
Mar 22,2021: Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Executive Officer
Feb 22,2021: Abeona Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Nov 09,2020: Abeona Therapeutics reports third quarter financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Abeona Therapeutics Inc – Key Facts
Abeona Therapeutics Inc – Key Employees
Abeona Therapeutics Inc – Key Employee Biographies
Abeona Therapeutics Inc – Major Products and Services
Abeona Therapeutics Inc – History
Abeona Therapeutics Inc – Company Statement
Abeona Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Abeona Therapeutics Inc – Business Description
Abeona Therapeutics Inc – Corporate Strategy
Abeona Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Abeona Therapeutics Inc – Strengths
Abeona Therapeutics Inc – Weaknesses
Abeona Therapeutics Inc – Opportunities
Abeona Therapeutics Inc – Threats
Abeona Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Abeona Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 25, 2021: Abeona Therapeutics Announces Appointment of Two New Independent Members to its Board of Directors
Mar 24, 2021: Abeona Therapeutics Announces 2020 Financial Results and Recent Operational Progress
Mar 22, 2021: Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Executive Officer
Feb 22, 2021: Abeona Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Nov 09, 2020: Abeona Therapeutics reports third quarter financial results
Oct 27, 2020: Abeona Therapeutics announces the appointment of Michael Amoroso as Chief Operating Officer
Oct 06, 2020: Abeona Therapeutics’ Board of Directors forms special committee to oversee operations, develop strategic direction and leadership plan
Sep 28, 2020: Abeona Therapeutics announces leadership and board transitions
Aug 10, 2020: Abeona Therapeutics reports second quarter financial results and business updates
Jul 09, 2020: Abeona Therapeutics announces appointment of Michael Amoroso as Chief Commercial Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Abeona Therapeutics Inc, Key Facts
Abeona Therapeutics Inc, Key Employees
Abeona Therapeutics Inc, Key Employee Biographies
Abeona Therapeutics Inc, Major Products and Services
Abeona Therapeutics Inc, History
Abeona Therapeutics Inc, Subsidiaries
Abeona Therapeutics Inc, Key Competitors
Abeona Therapeutics Inc, Annual Ratios
Abeona Therapeutics Inc, Annual Ratios (Cont...1)
Abeona Therapeutics Inc, Interim Ratios
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Abeona Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Abeona Therapeutics Inc (ABEO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • African Development Bank Group:企業の戦略的SWOT分析
    African Development Bank Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Awarepoint Corp:医療機器:M&Aディール及び事業提携情報
    Summary Awarepoint Corp (Awarepoint) is a healthcare technology company that provides real time location system. The company offers technology, software and managed services. It provides location software packages for mobile phones and other electronics. Awarepoint’s software packages provide patien …
  • Individual Restaurant Company Limited:企業の戦略・SWOT・財務分析
    Individual Restaurant Company Limited - Strategy, SWOT and Corporate Finance Report Summary Individual Restaurant Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Envipco Holding NV (ENVI):企業の財務・戦略的SWOT分析
    Envipco Holding NV (ENVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Samsung Electronics Co Ltd.:企業の戦略・SWOT・財務分析
    Samsung Electronics Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Electronics Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Japan Foods Co Ltd:企業の戦略・SWOT・財務情報
    Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • RockBridge Resources Inc (RBE):石油・ガス:M&Aディール及び事業提携情報
    Summary RockBridge Resources Inc (RockBridge) is an oil and gas exploration and development company. The company acquires, develops and explores oil and gas properties. Its properties include Twinning area, Open Creek property, Pembina and Brazeau property, and Bigoray area of Alberta. RockBridge’s …
  • GenMark Diagnostics Inc (GNMK):企業の財務・戦略的SWOT分析
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company offers products such as XT-8 systems and ePlex systems. It offers pipeline products include eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test, …
  • The Hain Celestial Group Inc (HAIN):企業の財務・戦略的SWOT分析
    The Hain Celestial Group Inc (HAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Casino Guichard-Perrachon SA:戦略・SWOT・企業財務分析
    Casino Guichard-Perrachon SA - Strategy, SWOT and Corporate Finance Report Summary Casino Guichard-Perrachon SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Lite-On Technology Corporation:企業の戦略・SWOT・財務情報
    Lite-On Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary Lite-On Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • TClarke PLC (CTO):企業の財務・戦略的SWOT分析
    TClarke PLC (CTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kolon Life Science Inc (102940):製薬・医療:M&Aディール及び事業提携情報
    Summary Kolon Life Science Inc (KLS) focuses on research and development, manufacture and commercialization of pharmaceutical products and active pharmaceutical ingredients (APIs). It develops innovative cell and gene therapeutics. The company's lead product is Invossa, the first cell-mediated gene …
  • Nanosonics Ltd (NAN)-医療機器分野:企業M&A・提携分析
    Summary Nanosonics Ltd (Nanosonics) is a medical technology company, which focuses on the development of technologies for infection control. Its product portfolio includes decontamination products and accessories for the prevention of hospital acquired infections (HAI). The company’s trophon EPR is …
  • Escorts Ltd:企業の戦略・SWOT・財務情報
    Escorts Ltd - Strategy, SWOT and Corporate Finance Report Summary Escorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Canam Group Inc:企業の戦略的SWOT分析
    Canam Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Poudre Valley Rural Electric Association, Inc.:発電所・企業SWOT分析
    Poudre Valley Rural Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, i …
  • Florida Power & Light Co:電力:M&Aディール及び事業提携情報
    Summary Florida Power & Light Company (FPL), a subsidiary of NextEra Energy, Inc., is a vertically-integrated electric utility that generates, transmits and distributes electricity. The company generates electricity from oil, natural gas, coal, nuclear and solar sources. It also purchases power and …
  • Total System Services Inc (TSS):企業の財務・戦略的SWOT分析
    Total System Services Inc (TSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • C&J Energy Services Inc (CJ):企業の財務・戦略的SWOT分析
    C&J Energy Services Inc (CJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆